EcoDrugPlus

Carbonic Anhydrase Xiv

Ensembl ID : ENSORLG00000010291
Gene Symbol: CA14
4 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSORLG00000014454
Gene Symbol: LOC101175322
3 Cross references
211 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSORLG00000002810
Gene Symbol: CSNK1E
4 Cross references
196 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSORLG00000002575
Gene Symbol: CASP9
4 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSORLG00000014228
Gene Symbol: COMTB
4 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSORLG00000010823
Gene Symbol: CTSC
4 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSORLG00000015716
Gene Symbol: CTSK
4 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSORLG00000003145
Gene Symbol: CTSS
3 Cross references
183 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSORLG00000015733
Gene Symbol: CTSS2.1
4 Cross references
233 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSORLG00000004956
Gene Symbol: CDC7
4 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSORLG00000005727
Gene Symbol: CHEK1
4 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSORLG00000024606
Gene Symbol: CHEK2
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).